Pifeltro OverviewDoravirine (MK-1439) is a non-nucleoside reverse transcriptase inhibitor developed by Merck & Co. for use in the treatment of HIV/AIDS. Doravirine demonstrated robust antiviral activity and good tolerability in a small clinical study of 7-day monotherapy reported at the 20th Conference on Retroviruses and Opportunistic Infections in March 2013. Doravirine appeared safe and generally well-tolerated with most adverse events being mild-to-moderate. In Au...
Read more Pifeltro Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Doravirine
Recent Pifeltro Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 100mg
NDC Database Records for Pifeltro: (1 result)Sorted by National Drug Code
- 0006-3069 Pifeltro 100 mg Oral Tablet, Film Coated by Merck Sharp & Dohme Corp.
Other drugs which contain Doravirine or a similar ingredient: (3 results)
- DELSTRIGO Doravirine + Lamivudine + Tenofovir Disoproxil Fumarate
- DORAVIRINE + LAMIVUDINE + TENOFOVIR DISOPROXIL FUMARATE